Lu Yu

Lu Yu, PhD, is a Director of Global Regulatory Affairs at AstraZeneca, where they have been leading efforts since 2021. Prior to this role, Lu served as a Regulatory Affairs Consultant at DLRC Regulatory Consultancy from 2018 to 2021, advising clients on regulatory strategies and managing submissions. They also held positions as a Senior Regulatory Affairs Associate Consultant at PAREXEL from 2015 to 2016 and as a Regulatory Affairs Associate Consultant. Lu completed postdoctoral research at University College London focused on gene therapy and at Harvard Medical School, specializing in bioanalytical and biomarker research. They earned their PhD in Biochemistry from The Hong Kong University of Science and Technology in 2005.